We believe services should have adequate funding to track symptoms and create clear treatment pathways for PMDD (Premenstrual Dysphoric Disorder) & menopause.

PMDD affects 1 in 20 women & people who menstruate, with some sources citing that almost a third attempt suicide. PMDD, PME (Premenstrual Exacerbation) & menopause can mimic psychiatric illness, leading to misdiagnosis, unsafe treatment, & preventable harm. There is no dedicated mental health pathway for PMDD. Neurodivergent women are disproportionately affected. Menopause will impact nearly all women. We think that including menstrual and menopausal health in assessments could reduce suicide risk, improve diagnosis, & ensure safer, more effective care.